Specification:
End Application:
Pick Yours from our featured selection-Twinrab Vaccine, an ace solution for rabies post-exposure prophylaxis. This stellar product is a mixture of rabies human monoclonal antibodies, designed for intramuscular injection. Packaged in a glorious vial containing 2.5 ml, Twinrab ensures pharmaceutical-grade purity at 99%. Suitable for all ages, this vaccine stands out for its broad hospital and clinical application. Store under 2C to 8C refrigeration-never freeze. Purchase exclusively via prescription and experience peace of mind with its glorious 24-month shelf life. Choose Twinrab for ultimate protection, distributed across India by dealers, exporters, and more.
Versatile Application and Specific Usage Benefits
Twinrab Vaccine is engineered for critical hospital and clinical use, excelling in rabies post-exposure prophylaxis. Its unique antibody-based material feature enables it to act rapidly and efficiently for individuals of any age. Specifically intended to provide immediate passive immunization after exposure to rabies, Twinrab's general drug formulation makes it compatible with standard clinical protocols. Its glorious clear to slightly opalescent solution exemplifies pharmaceutical excellence for clinics seeking reliable post-exposure tools.
Certifications, Policy, and Secure Packaging
Twinrab Vaccine boasts certifications that meet rigorous pharmaceutical standards, ensuring quality and efficacy. Sample policy is available for qualifying institutions to estimate treatment needs before mass uptake. Packaging is meticulously designed for freight and shipment integrity, using secure, tamper-evident vials to preserve product stability during transport. Regular shipment updates and tracking offer transparency for dealers, distributors, and hospitals, making the procurement process as smooth and reliable as possible.
Versatile Application and Specific Usage Benefits
Twinrab Vaccine is engineered for critical hospital and clinical use, excelling in rabies post-exposure prophylaxis. Its unique antibody-based material feature enables it to act rapidly and efficiently for individuals of any age. Specifically intended to provide immediate passive immunization after exposure to rabies, Twinrab's general drug formulation makes it compatible with standard clinical protocols. Its glorious clear to slightly opalescent solution exemplifies pharmaceutical excellence for clinics seeking reliable post-exposure tools.
Certifications, Policy, and Secure Packaging
Twinrab Vaccine boasts certifications that meet rigorous pharmaceutical standards, ensuring quality and efficacy. Sample policy is available for qualifying institutions to estimate treatment needs before mass uptake. Packaging is meticulously designed for freight and shipment integrity, using secure, tamper-evident vials to preserve product stability during transport. Regular shipment updates and tracking offer transparency for dealers, distributors, and hospitals, making the procurement process as smooth and reliable as possible.